SEARCH

SEARCH BY CITATION

References

  • 1
    Magee LA , Helewa M , Moutquin JM , von Dadelszen P ; Hypertension Guideline Committee, Strategic Training Initiative in Research in the Reproductive Health Sciences (STIRRHS) Scholars. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can 2008;30(Suppl 3):S148.
  • 2
    National Institute for Health and Clinical Excellence (NICE). Hypertension in Pregnancy: The management of hypertensive disorders during pregnancy. 2010; NICE clinical guideline 107:1295.
  • 3
    Society of Obstetric Medicine of Australia and New Zealand (SOMANZ). Guidelines for the management of hypertensive disorders of pregnancy 2008. [www.somanz.org/guidelines.asp]
  • 4
    Martin JNJ , Thigpen BD , Moore RC , Rose CH , Cushman J , May W . Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol 2005;105:24654.
  • 5
    Centre for Maternal and Child Enquiries (CMACE). Saving Mothers' Lives: reviewing maternal deaths to make motherhood safer: 2006–08. The Eighth Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011;118:1203.
  • 6
    World Health Organization. WHO Recommendations for Prevention and Treatment of Pre-Eclampsia and Eclampsia. Geneva: WHO; 2011.
  • 7
    Magee LA , Ornstein MP , Von Dadelszen P . Management of hypertension in pregnancy. BMJ 1999;318:13326.
  • 8
    Magee LA , von Dadelszen P . The management of severe hypertension. Semin Perinatol 2009;33:13842.
  • 9
    Magee L , Cham C , Waterman E , Ohlsson A , von Dadelszen P . Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ 2003;327:95560.
  • 10
    Duley L , Henderson-Smart D , Meher S . Drugs for the treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev 2006; CD001449.
  • 11
    PRISMA. Transparent Reporting of Systematic Reviews and Meta-Analyses. [www.prisma-statement.org/statement.htm]. Accessed 18 October 2012.
  • 12
    Brown M , Buddle M , Farrell T , Davis G . Efficacy and safety of nifedipine tablets for the acute treatment of severe hypertension in pregnancy. Am J Obstet Gynecol 2002;187:104650.
  • 13
    Martins-Costa S , Ramos J , Barros E . Randomized, controlled trial of hydralazine versus nifedipine in pre-eclamptic women with acute hypertension. Clin Exper Hypertens Pregn 1992;11:2543.
  • 14
    de Souza MR , Nagib A , Bertini AM . Use of hydralazine and nifedipine in hypertensive emergency in pregnancy [Empleo de la hidralazina y de la nifedipina en las emergencias hipertensivas en la gestacion]. Progr Obstet Ginecol 1994;37:906.
  • 15
    Aali BS , Nejad SS . Nifedipine or hydralazine as a first-line agent to control hypertension in severe preeclampsia. Acta Obstet Gynecol Scand 2002;81:2530.
  • 16
    Rezaei Z , Sharbaf FR , Pourmojieb M , Youefzadeh-Fard Y , Motevalian M , Khazaeipour Z , et al. Comparison of the efficacy of nifedipine and hydralazine in hypertensive crisis in pregnancy. Acta Med Iran 2011;49:7016.
  • 17
    Raheem I , Saaid R , Omar S , Tan P . Oral nifedipine versus intravenous labetelol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial. BJOG 2011;119:7885.
  • 18
    Rodriguez RJW , Amaya LAH . Pre-eclampsia severa. Nifedipina versus chlorpromazina en el manejo del estado hipertensivo agudo. Rev Med Inst Mex Seguro Soc 1989;27:35963.
  • 19
    Walss Rodriguez RJ , Flores Padilla LM . Management of severe pre-eclampsia/eclampsia. Comparison between nifedipine and hydralazine as antihypertensive agents. Ginecol Obstet Mex 1993;61:769.
  • 20
    Duggan PM , McCowan LM , Stewart AW . Antihypertensive drug effects on placental flow velocity waveforms in pregnant women with severe hypertension. Aust N Z J Obstet Gynaecol 1992;32:3358.
  • 21
    Seabe S , Moodley J , Becker P . Nifedipine in acute hypertensive emergencies in pregnancy. S Afr Med J 1989;76:24850.
  • 22
    Hall DR , Odendaal HJ , Steyn DW , Smith M . Nifedipine or prazosin as a second agent to control early severe hypertension in pregnancy: a randomised controlled trial. BJOG 2000;107:75965.
  • 23
    Vermillion ST , Scardo JA , Newman RB , Chauhan SP . A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy. Am J Obstet Gynecol 1999;181:85861.
  • 24
    Walss Rodriguez RJ , Villarreal Ordaz F . Management of severe pre-eclampsia in the puerperium. Comparative study of sublingual nifedipine and hydralazine. Ginecol Obstet Mex 1991;59:20710.
  • 25
    Moore MP , Redman C . The treatment of hypertension in pregnancy. Curr Med Res Opin 1982;8:3946.
  • 26
    Voto LS , Zin C , Neira J , Lapidus AM , Margulies M . Ketanserin versus α-methyldopa in the treatment of hypertension during pregnancy: a preliminary report. J Cardiovasc Pharmacol 1987;10(Suppl 3):S1013.
  • 27
    Vargas Ayala G , Salmeron Perez I , Sanchez Garcia AR , Jimenez Acevedo AL , Rubio Guerra AF . Efficacy of isosorbide in aerosol form in the management of hypertensive crisis in severe preeclampsia. Ginecol Obstet Mex 1998;66:3169.
  • 28
    The use of hydralazine and nifedipine as treatment of hypertension emergency during pregnancy. Proceedings of 2nd World Congress of Perinatal Medicine; September 19–24; Rome, Italy; 1993.
  • 29
    Prazosin or nifedipine as a second agent to control early severe hypertension in pregnancy - a randomized controlled trial. 29th Congress of the South African Society of Obstetricians and Gynaecologists; March 8–12; South Africa; 1998.
  • 30
    Jayawardana J , Lekamge N . A comparison of nifedipine with methyldopa in pregnancy induced hypertension. Ceylon Med J 1994;39:8790.
  • 31
    Visser W , Wallenburg HC . A comparison between the haemodynamic effects of oral nifedipine and intravenous dihydralazine in patients with severe pre-eclampsia. J Hypertens 1995;13:7915.
  • 32
    Wide-Swensson D , Ingemarsson I , Lunell NO , Forman A , Skajaa K , Lindberg B , et al. Calcium channel blockade (isradipine) in treatment of hypertension in pregnancy: a randomized placebo-controlled study. Am J Obstet Gynecol 1995;173:8728.
  • 33
    Treatment of severe hypertension in pregnancy. Double blind controlled trial a treatment pattern (T.P.) with hydralazine + methyldopa a single T.P. with labetalol. 6th International Congress of the International Society for the Study of Hypertension in Pregnancy; May 22–26; Montreal, Canada; 1988.
  • 34
    A randomized controlled trial of oral nifedipine vs intravenous labetalol in acute control of blood pressure in hypertensive emergencies of pregnancy. 54th All India Congress of Obstetrics and Gynaecology; Jan 5–9; Hyderabad, India; 2011.
  • 35
    Aswathkumar R , Gilvaz S . Management of severe hypertension in pregnancy: prospective comparison of labetalol vs nifedipine [abstract]. 2006.
  • 36
    Gradman A, Basile J, Carter B, Bakris G; American Society of Hypertension Writing Group. Combination therapy in hypertension. J Am Soc Hypertens 2010;4:4250.
  • 37
    Brown MA , Wang J . W JA. The Renin — Angiotensin — Aldosterone System in Pre-Eclampsia. Clin Exp Hypertens 1997;19:71326.
  • 38
    Tuffnell D , Jankowicz D , Lindow S , Lyons G , Mason G , Russell I . Outcomes of severe pre-eclampsia/eclampsia in Yorkshire 1999/2003. Yorkshire Obstetric Critical Care Group. BJOG 2005;112:87580.
  • 39
    Furberg CD , Psaty BM , Meyer JV . Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:132631.
  • 40
    Brown M , McCowan L , North R , Walters B . Withdrawal of nifedipine capsules: jeopardizing the treatment of acute severe hypertension in pregnancy? Australasian Society for the Study of Hypertension in Pregnancy. Med J Aust 1997;166:6403.
  • 41
    Magee L , Miremadi S , Li J , Cheng C , Ensom M , Carleton B , et al. Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia. Am J Obstet Gynecol 2005;193:15363.
  • 42
    Shahzad K , Akhtar S , Mahmud S . Prevalence and determinants of asthma in adult male leather tannery workers in Karachi, Pakistan: a cross sectional study. BMC Public Health 2006;6:292.
  • 43
    Hasnain S , Khan M , Saleem A , Waqar M . Prevalence of asthma and allergic rhinitis among school children of Karachi, Pakistan, 2007. J Asthma 2009;46:8690.
  • 44
    Asthma prevalence increasing by 5% annually. [www.pakrealestatetimes.com/showthread.php?tid=4741]. Accessed 30 March 2012.
  • 45
    World Health Organization. Priority Life-Saving Medicines for Women and Children 2012. Geneva: WHO; 2012.
  • 46
    Lalani S , Firoz T , Magee L , Sawchuck D , Payne B , Gordon R , et al. Pharmacotherapy for pre-eclampsia in low and middle income countries: an analysis of Essential Medicines Lists (EMLs). J Obstet Gynaecol Can 2013;35:21523.
  • 47
    Redman CWG , Kelly JG , Cooper WD . The excretion of enalapril and enalaprilat in human breast milk. Eur J Clin Pharmacol 1990;38:99.
  • 48
    LactMed. Captopril. [http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~zeY44U:1]. Accessed 3 October 2012.